When I recognize my frustration and dissapointment with the test results for my chronic lymphocytic leukemia, I find comfort ...
From the death of folk music star Peter Yarrow of Peter, Paul and Mary to good news from broadcasting legend Dick Vitale, ...
For patients with advanced or recurrent endometrial cancer, first-line Lenvima plus Keytruda didn’t significantly improve ...
The FDA has granted BTD to GSK’22, a B7-H3-targeted antibody-drug conjugate, for the treatment of adult patients with ...
Both laparoscopic wedge and endoscopic resection are safe and feasible treatment approaches for patients with gastric ...
As I shift from an oncologist to a gynecologist for breast screenings, I examine both my reluctance to let go of the past and ...
Low-dose oral minoxidil, the hair growth drug which is the active ingredient in Rogaine, may be safe and effective for ...
A panelist discusses how patients with polycythemia vera (PV) often present with diverse symptoms ranging from fatigue and itching to cardiovascular complications, leading doctors to conduct specific ...
Real-world data supports Opdivo plus Yervoy efficacy for advanced renal cell carcinoma, mirroring clinical trial results.
First-line Rybrevant plus Lazcluze improved survival versus the current standard of care in patients with mutated advanced or ...
Dr. Eric K. Singhi discusses the benefit of subcutaneous immunotherapy following the FDA approval of subcutaneous Opdivo for ...
Every treatment bag should include an unlimited supply of humor. Stuff will happen. It’ll be hard, but you may learn to laugh ...